Abbott and Tandem Diabetes Care announced that they have finalized an agreement to develop and commercialize integrated …
CGMs, Meters & Pumps
Introducing Pip: The Lancet You Never Have to Change
Sponsored Post:
Have you ever thought about upgrading your lancet system? I myself use the lancing device that my doctor…
FDA Approves Tandem’s t:slim X2 Insulin Pump with Control-IQ for Children Age 6 and Up
The U.S. FDA has announced clearance of an expanded pediatric indication for the Tandem’s t:slim X2™ insulin pump with …
DreaMed Uses AI to Improve Diabetes Management
With the recent proliferation of advanced diabetes technology, people with Type 1 diabetes now enjoy an unprecedented ab…
Does Diabetes Technology Have a Race Problem?
Does diabetes technology have a race problem? Are the latest devices least available to those that need them most?
On th…
Can Technology Alone Prevent Hypoglycemia?
The threat of hypoglycemia remains one of the most dangerous facts of life with diabetes, both as an immediate and poten…
Fighting COVID-19 with the Dexcom G6
In an “unprecedented” move, the FDA has granted temporary permission for Dexcom to provide G6 continuous glucose monitor…
Eversense Implantable Glucose Monitor Halts Sales Amid COVID Outbreak
Senseonics, the maker of the Eversense 90-day implantable continuous glucose monitor (CGM), has halted all new sales and…
Diabetes Technology is Better, So Why are Outcomes Worse?
We are very lucky to live in an age of so much marvelous technological and pharmacological innovation. The tools we have…
FDA Recalls Medtronic Minimed 630G and 670G Insulin Pumps
The FDA has issued a Class I recall, the most serious type of recall for Medtronic’s Minimed 600 Pump Series. Use…
